← Back to Search

Acceptance and Commitment Therapy for Caregiver Stress

N/A
Recruiting
Led By Areum Han, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Community-dwelling adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to immediately after the intervention and 3 month follow-up
Awards & highlights

Study Summary

This trial is testing whether a coach-guided online intervention can help reduce distress and burden for family caregivers of people with dementia, compared to a control group.

Who is the study for?
This trial is for adult family caregivers of people with dementia who have mild depression, can give informed consent, and have internet access. It's not for those with cognitive impairments, recent psychiatric hospitalizations or severe mental illness diagnoses, on certain medications, planning to institutionalize their relative soon, or likely to drop out due to health issues.Check my eligibility
What is being tested?
The study tests a ten-week online Acceptance and Commitment Therapy (ACT) program guided by a coach against a control group. The goal is to see if the ACT group experiences better mental health outcomes including reduced depressive symptoms after the program and at a three-month follow-up.See study design
What are the potential side effects?
As this trial involves psychoeducation and therapy rather than medication, typical medical side effects are not expected. Participants may experience emotional discomfort as they engage in therapeutic activities designed to address depression related to caregiving.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and the main caregiver for a family member with dementia living at home.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to immediately after the intervention and 3 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to immediately after the intervention and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline to immediately after the intervention and 3 month follow-up on the Patient Health Questionnaire-9
Secondary outcome measures
Change from baseline to immediately after the intervention and 3 month follow-up on the Action and Acceptance Questionnaire-II
Change from baseline to immediately after the intervention and 3 month follow-up on the Caregiver Guilt Questionnaire
Change from baseline to immediately after the intervention and 3 month follow-up on the Cognitive Fusion Questionnaire
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Acceptance and commitment therapy (ACT) groupExperimental Treatment1 Intervention
10 weekly ACT sessions individually guided by a trained coach through Zoom videoconferencing with psychoeducation materials provided
Group II: Psychoeducation control groupPlacebo Group1 Intervention
Care as usual with psychoeducation materials provided

Find a Location

Who is running the clinical trial?

Alzheimer's AssociationOTHER
90 Previous Clinical Trials
40,709 Total Patients Enrolled
2 Trials studying Depression
281 Patients Enrolled for Depression
University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,418 Total Patients Enrolled
23 Trials studying Depression
2,565 Patients Enrolled for Depression
Areum Han, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
7 Previous Clinical Trials
196 Total Patients Enrolled
4 Trials studying Depression
160 Patients Enrolled for Depression

Media Library

Acceptance and commitment therapy (ACT) Clinical Trial Eligibility Overview. Trial Name: NCT05043441 — N/A
Depression Research Study Groups: Acceptance and commitment therapy (ACT) group, Psychoeducation control group
Depression Clinical Trial 2023: Acceptance and commitment therapy (ACT) Highlights & Side Effects. Trial Name: NCT05043441 — N/A
Acceptance and commitment therapy (ACT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05043441 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What therapeutic goals is this medical experiment attempting to achieve?

"This clinical trial's primary aim is to observe changes in the Patient Health Questionnaire-9. Secondary goals include measuring cognitive fusion levels with the Cognitive Fusion Questionnaire -7, assessing clarity and engagement with personal values via Engaged Living Scale -9, and evaluating grief of caregivers through Marwit-Meuser Caregiver Grief Inventory Brief-Form over a Change from baseline to immediately after the intervention and 3 month follow-up time frame."

Answered by AI

Can new participants join this medical research experiment?

"Per information available on clinicaltrials.gov, this trial is currently accepting participants and was initially posted on March 21st 2022 with the most recent update taking place on September 30th 2022."

Answered by AI

How many participants are being incorporated into this experiment?

"Affirmative. Clinicaltrials.gov confirms that this medical study, originally posted on March 21st 2022 and last updated September 30th 2022, is actively recruiting patients to join the experiment with a target of 64 participants at one site."

Answered by AI

Who else is applying?

What state do they live in?
Alabama
What site did they apply to?
University of Alabama at Birmingham
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
2
Recent research and studies
clinicaltrials.govStudy
A Ten-Week Online Acceptance and Commitment Therapy Intervention for Family Caregivers of People With Dementia
Areum Han 2022. "A Ten-Week Online Acceptance and Commitment Therapy Intervention for Family Caregivers of People With Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05043441.
~17 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top